1. Home
  2. XELB vs PYPD Comparison

XELB vs PYPD Comparison

Compare XELB & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XELB
  • PYPD
  • Stock Information
  • Founded
  • XELB 2011
  • PYPD 2008
  • Country
  • XELB United States
  • PYPD Israel
  • Employees
  • XELB N/A
  • PYPD N/A
  • Industry
  • XELB Multi-Sector Companies
  • PYPD Medical/Dental Instruments
  • Sector
  • XELB Miscellaneous
  • PYPD Health Care
  • Exchange
  • XELB Nasdaq
  • PYPD Nasdaq
  • Market Cap
  • XELB 19.0M
  • PYPD 19.4M
  • IPO Year
  • XELB N/A
  • PYPD 2020
  • Fundamental
  • Price
  • XELB $0.51
  • PYPD $3.06
  • Analyst Decision
  • XELB
  • PYPD Strong Buy
  • Analyst Count
  • XELB 0
  • PYPD 2
  • Target Price
  • XELB N/A
  • PYPD $10.50
  • AVG Volume (30 Days)
  • XELB 359.0K
  • PYPD 49.2K
  • Earning Date
  • XELB 12-20-2024
  • PYPD 02-12-2025
  • Dividend Yield
  • XELB N/A
  • PYPD N/A
  • EPS Growth
  • XELB N/A
  • PYPD N/A
  • EPS
  • XELB N/A
  • PYPD N/A
  • Revenue
  • XELB $9,337,000.00
  • PYPD N/A
  • Revenue This Year
  • XELB N/A
  • PYPD N/A
  • Revenue Next Year
  • XELB $82.99
  • PYPD N/A
  • P/E Ratio
  • XELB N/A
  • PYPD N/A
  • Revenue Growth
  • XELB N/A
  • PYPD N/A
  • 52 Week Low
  • XELB $0.33
  • PYPD $2.37
  • 52 Week High
  • XELB $1.70
  • PYPD $9.20
  • Technical
  • Relative Strength Index (RSI)
  • XELB 43.26
  • PYPD 49.59
  • Support Level
  • XELB $0.33
  • PYPD $2.62
  • Resistance Level
  • XELB $0.53
  • PYPD $3.24
  • Average True Range (ATR)
  • XELB 0.09
  • PYPD 0.40
  • MACD
  • XELB 0.01
  • PYPD 0.03
  • Stochastic Oscillator
  • XELB 43.27
  • PYPD 46.62

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain design, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: